期刊文献+

ER表达状态乳腺癌差异表达microRNAs相关信号通路的分析 被引量:2

Bioinformatics-based analysis of signaling pathways for differently expressed microRNAs between different ER status breast cancers
原文传递
导出
摘要 目的:利用生物信息的方法,建立一种对不同ER表达状态乳腺癌差异表达microRNAs生物学功能和信号通路系统分析的方法,探讨microRNAs在不同ER状态中可能发挥的调控作用。方法:通过文献挖掘,找出不同ER表达状态乳腺癌差异表达microRNAs,利用预测软件TargetScan、PicTar、miRanda和TarBase数据库得出microRNAs可能靶向的基因集,对靶基因集进行去除随机化的富集分析后,再利用DAVID数据库进行相关生物学功能和信号通路分析。结果:通过文献挖掘的方法找到了5个不同ER表达状态乳腺癌microRNAs差异表达数据集,分别包含了11、43、25、6及19个差异表达的microRNAs。经过靶基因预测及富集后,得到的不同microRNAs靶基因集分别包括1 553、1 750、1 905、1 250和1 826个靶基因。进一步功能及通路分析发现,这些靶基因集可能参与转录相关蛋白质定位及转移、RNA代谢、细胞周期、细胞凋亡和细胞分裂等多个生物学过程,并发现3条共同的BIOCARTA细胞信号通路可能与ER表达调节相关。结论:找到了不同ER表达状态乳腺癌差异表达的microRNAs,并利用生物信息学方法对这些mi-croRNAs进行系统分析,为进一步研究microRNAs在乳腺癌不同分子亚型分化中的调控机制奠定基础。 OBJECTIVE: To develop a bioinformatics-based approach for analysis of cellular functions and pathways affected by differently expressed microRNAs in different ER status of breast cancers and explore the regulatory roles of microRNAs. METHODS: By literature metrological methods,aberrant expressed microRNAs were collected. By target prediction algorithm TargetScan,PicTar and miRanda, TarBase database and data enrichment analysis as well as target gene sets of differently expressed microRNAs were built. Then by usijag of DAVID database, Gene Ontology categories and biological functions as well as signaling pathways that are probably regulated by differently expressed microRNAs were analysed. RESULTS: Five sets of microRNAs including 11,43,25,6 and 19 respectively were found. After microR NAs target prediction and a two-step data enrichment procedure,1 553,1 750,1 905,1 250 and 1 826 target genes of 5 mi croRNA sets were collected. Gene Ontology analysis suggested these genes might involve in transcription, protein location and transport, RNA metabolism, cell cycle and apoptosis. Also, 3 BIOCARTA signal pathways correlating with ER status were found. CONCLUSION: This bioinformatics-based approach for analysis of differently microRNAs in different ER status breast cancers provides a new method for biological interpretation of microRNAs profiling data,and may be helpful to understand the regulatory roles of mieroRNAs in different molecular subtypes of breast cancers.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第23期1795-1799,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 卫生部科技专项基金(W2009BX015)
关键词 乳腺肿瘤 受体 雌激素 MICRORNAS 信号传导 计算生物学 breast neoplasms recepters,estrogen microRNAs signal transduction computational biology
  • 相关文献

参考文献22

  • 1Pasquinelli AE. MicroRNAs and their targets., recognition,regu- lation and an emerging reciprocal relationship[J]. Nat Rev Gen- et, 2012,13(4) : 271-282.
  • 2Nair VS, Maeda LS,Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer.- a systematic review[J]. J Nat/ Cancer Inst, 2012,104 (7) : 528-540.
  • 3Adams BD,Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptovalpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines[J]. Mol Endocrinol,2007, 21(5) : 1132-1147.
  • 4Rao X,Di Leva G, Li M, et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling path- ways[J]. Oncogene,2011,30(9) : 1082-1097.
  • 5Miller TE,Ghoshal K,Ramaswarny B,et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kipl [J]. J giol Chem,2008,283(4),29897-29903.
  • 6Pandey DP,Picard D. miR 22 inhibits estrogen signaling by di- rectly targeting the estrogen receptor alpha mRNA[J]. Mol Cell Biol, 2009,29 (13) : 3783-3790.
  • 7Bartel DP. MicroRNAs:target recognition and regulatory rune tions [J]. Cell, 2009,136 (2) : 215-233.
  • 8lorio MV,Ferracin M,Liu CG,et al. MicroRNA gene expression deregulation in human breast caneer[J]. Cancer Res, 2005,65 (16) :7065-7070.
  • 9Mattie MD, Benz CC, Bowers J, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assess- ment of clinical prostate and breast cancer biopsies [J]. Mol Cancer, 2006,5 : 24.
  • 10Blenkiron C, Goldstein LD, Thorne NP, et al. MicroRNA expressionprofiling of human breast cancer identifies new markers of tumor sub- type[J]. Genome Biol,2007,8(10) :R214.

二级参考文献24

  • 1Bartel DP. MicroRNAs: genomics , biogenesis , mechanism, and fnnction[J]. Cell, 2004, 116(2) : 281-297.
  • 2Baranwal S, Alahari SK.miRNA control of rumor cell invasion and metastasis[J]. IntJ Cancer, 2010, 126(6): 1283-1290.
  • 3Croce CM. Causes and consequences of microRNA dysregulation in cancer[J]. Nat Rev Genet, 2009, 10(10): 704-714.
  • 4Garzon R, Calin GA, Croce CM. MicroRNAs in cancer[J]. Annu Rev Med, 2009, 60: 167-179.
  • 5Jopling CL, Norman KL, Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver--specific microRNA miR-122[J].Cold Spring Harb Symp Quant Biol, 2006, 71: 369-376.
  • 6Alexiou P, Vergoulis T, Gleditzsch M, et al. miRGen 2.0: a database of microRNA genomic information and regulation[J]. Nucleic Acids Res, 2010, 38(Database issue): D137-D141.
  • 7ThomsonJM, Parker j, Perou CM, et al. A custom microarray platform for analysis of microRNA gene expression[J]. Nat Methods, 2004, 1(1): 47-53.
  • 8Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma[J]. Cancer Res, 2007, 67(13): 6092-6099.
  • 9Li Q Wang G, Shan JL, et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion[J]. J Gastroenterol Hepatol, 2010, 25(1): 164-171.
  • 10Santarpia L, EI-Naggar AK, Cote GJ, et al. Phosphatidylinositol 3--kinase/akt and ras/raf-mitogenactivated protein kinase pathway mutations in anaplastic thyroid cancer[J], j Clin Endocrinol Metab, 2008, 93(1): 278-284.

共引文献5

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部